Since July 2012, when our program became ACGME accredited, our fellows have published peer-reviewed journal articles and have presented numerous abstracts, posters, and oral presentations at local, regional, national and international meetings such as the American Heart Association (AHA), Heart Failure Society of America (HFSA) and the International Society for Heart and Lung Transplantation (ISHLT).
Right Ventricular Dysfunction and Its Contribution to Morbidity and Mortality in Left Ventricular Heart Failure.
Raina A, Meeran T.
Curr Heart Fail Rep. 2018 Apr;15(2):94-105. doi: 10.1007/s11897-018-0378-8. Review.
Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
Kassis, H, Cherukuri K, Agarwal R, Kanwar M, Elapavaluru S, Sokos GG, Moraca RJ, Bailey SH, Murali S, Benza RL, Raina A.
JACC Heart Fail. 2017 Feb;5(2):81-88. doi: 10.1016/j.jchf.2016.09.014. Epub 2016 Dec 21.
Airhart, S, Walters C, Verlinden N, Correa P, Franco V, Raina A, Benza R. “Safety of Outpatient Transition from Intravenous Treprostinil To An Oral Prostacyclin Analog Using Remote Wireless Hemodynamic Monitoring” International Society of Heart & Lung Transplantation Annual Meeting, Oral Session: Junior Faculty Clinical Case Dilemmas in Thoracic Transplantation: The Best of the Best, April 2017, San Diego
Airhart, S, Kassis H, Cherukuri K, Moraca B, Bailey S, Agarwal R, Raina A. “Left Ventricular Reverse Remodeling Is Associated with LVAD Speed Indexed for Body Surface Area but Not Raw Pump Speed in the Heartmate II Device” International Society of Heart & Lung Transplantation Annual Meeting, Poster Session, April 2017, San Diego
Airhart S, Khariton Y, Lombardi W, Gosch K, Sapontis J, Grantham J, McCabe J. “Quality of Life Benefits of Successful Chronic Total Occlusion PCI in Patients with Depressed Left Ventricular Systolic Function: Insights from the OPEN-CTO Registry” American College of Cardiology, Poster Session, March 2017, Washington D.C.
Airhart, S, Raina A. “Reducing the Burden of Parenteral Prostacyclin Therapy: The Totally Implantable Prostacyclin System”. ISHLT Links Vol 8, Issue 7.
Airhart, S, Murali S: Ischemic Cardiomyopathy for the Encyclopedia of Cardiovascular Research and Medicine (submitted and accepted)
Phosphodiesterase type 5 inhibitor to riociguat transition is associated with hemodynamic and symptomatic improvement in pulmonary hypertension.
Davey R, Benza RL, Murali S, Raina A.
Pulm Circ. 2017 Apr-Jun;7(2):539-542. doi: 10.1177/2045893217708566. Epub 2017 May 12.
Hemodynamic response to treatment of iron deficiency anemia in pulmonary arterial hypertension: longitudinal insights from an implantable hemodynamic monitor.
Mehmood M, Agarwal R, Raina A, Correa-Jaque P, Benza RL.
Pulm Circ. 2016 Dec;6(4):616-618. doi: 10.1086/688670.
Hemodynamic Benefits of Oral Iron Supplementation for Anemia in Pulmonary Arterial Hypertension: Novel Insights from Wireless Hemodynamic
Abstract Junior Faculty Poster/Case Report Presentation – ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC
2016, April 29
Pulmonary Hypertension and Pulmonary Thrombo-embolic Disease II; Inflammatory Cytokines and Markers of Vascular Remodeling and Angiogenesis Are Associated With Functional Capacity. Hospitalizations and NT-ProBNP Levels in Patients With Pulmonary Arterial Hypertension
Davey, Ryan A.
Poster Abstract Presentation- ACC 65th Annual Meeting and Scientific Sessions, Chicago, IL
2016, April 3
Biomarkers of Pulmonary Arterial Hypertension
Abstract Poster Presentation – American Heart Association Scientific Sessions 2015, Orlando, FL
2015, November 9
Evaluation of End Stage Heart Failure Patients on Inotropic Therapy in the Defibrillator Era
Authors: M. Caccamo, M. Barnes, S. Murali, R.L. Benza, M. Kanwar, A. Raina, R. Agarwal, D. V. Thompson, G.G. Sokos
Poster Presentation – ISHLT 33rd Annual Meeting and Scientific Sessions, Montreal
2013, April 24
Copyright © 2021 Allegheny Health Network. All rights reserved